TN SB0465AI summary is being generated. Check back soon for a plain-language breakdown of this bill.
Positive media analysis is being generated.
Critical media analysis is being generated.
Senator Todd Gardenhire, the sponsor of SB0465, has personal financial interests that align directly with the pharmaceutical industry, which is significantly impacted by the proposed legislation. Specifically, he holds assets in major pharmaceutical companies such as Pfizer and Eli Lilly & Co. These companies could potentially benefit from changes in drug policy, particularly in relation to substance use and overdose immunity, as they are involved in the production of medications that may be prescribed in such contexts. The bill's aim to amend the legal framework surrounding drug overdoses could influence the market dynamics for these pharmaceutical products, thereby presenting a potential conflict of interest for the sponsor.
Given that the bill seeks to remove limitations on immunity for individuals experiencing drug overdoses, it could lead to increased usage of certain medications that are produced by the companies in which Senator Gardenhire has invested. This creates a scenario where his financial interests in Pfizer and Eli Lilly may be positively affected by the legislation, raising concerns about whether his personal financial gain could influence his legislative decisions. The direct alignment of his assets with the pharmaceutical sector suggests a high risk of conflict of interest.
Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.
| Type | Description | Industry | Source |
|---|---|---|---|
| Occupation | Financial Advisor | — | AI-researched |
| Employer | Retired from Morgan Stanley | Securities & Investment | TN Legislature bio |
| Board Member | Board member of the Tennessee Student Assistance Corporation | — | TN Legislature bio |
| Spouse Employer | INTERNATIONAL BUSINESS MACHINE PENSION ANNUITY | — | TN Ethics Commission |
| Employer | METLIFE PENSION ANNUITY | — | TN Ethics Commission |
| Employer | SOCIAL SECURITY | — | TN Ethics Commission |
| Employer | SEP IRA RMD | — | TN Ethics Commission |
| Employer | MORGAN STANLEY COMMON STOCK | Securities & Investment | TN Ethics Commission |
| Asset | MORGAN STANLEY COMMON | Securities & Investment | TN Ethics Commission |
| Asset | BROWN CAPITAL SMALL CAP | — | TN Ethics Commission |
| Asset | JANUS HENDERSON ENTERPRISE N | — | TN Ethics Commission |
| Asset | ALLIANZ NFJ LARGE CAP VALUE | — | TN Ethics Commission |
| Asset | NATIONAL HEALTHCARE CORP | — | TN Ethics Commission |
| Asset | SPROTT PHYSICAL GOLD TRUST | — | TN Ethics Commission |
| Asset | CUSIP 9128285T3 | — | TN Ethics Commission |
| Asset | CUSIP 912828XZ8 | — | TN Ethics Commission |
| Asset | CUSIP 91282CEU1 | — | TN Ethics Commission |
| Asset | CUSIP 91282CFP1 | — | TN Ethics Commission |
| Asset | FIFTH 3D BANCORP | — | TN Ethics Commission |
| Asset | FIRST HORIZON CORP | — | TN Ethics Commission |
| Asset | REGIONS FINANCIAL | — | TN Ethics Commission |
| Asset | ASTEC INC. | — | TN Ethics Commission |
| Asset | SANOFI | — | TN Ethics Commission |
| Asset | PFIZER | Pharmaceuticals/Health Products | TN Ethics Commission |
| Asset | ELI LILLY & CO | Pharmaceuticals/Health Products | TN Ethics Commission |
| Asset | BRISTOL MYERS SQUIBB & CO | — | TN Ethics Commission |
| Asset | ASTRAZENECA PLC ADR | — | TN Ethics Commission |
| Asset | EXXON MOBIL | Oil & Gas | TN Ethics Commission |
Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.
